Nucala approved in China for use in severe asthma with an eosinophilic phenotype
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
The deal includes upfront payments, milestone payments and ongoing royalties
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
        Subscribe To Our Newsletter & Stay Updated